105 results on '"Kanou, Kazuhiko"'
Search Results
2. Epidemiologic trends and distributions of imported infectious diseases among travelers to Japan before and during the COVID-19 pandemic, 2016 to 2021: a descriptive study
3. Nationwide epidemiologic and genetic surveillance of hepatitis E in Japan, 2014–2021.
4. Reduced mortality during the COVID-19 outbreak in Japan, 2020: a two-stage interrupted time-series design
5. Viral and Immunological Characteristics of COVID-19 Vaccine Breakthrough Infections
6. Clinical Characteristics and Risk Factors for Severe Outcomes of Novel Coronavirus Infection, January–March 2020, Japan
7. Topology of AspT, the aspartate:alanine antiporter of Tetragenococcus halophilus, determined by site-directed fluorescence labeling
8. Identification of amino acid residues of Salmonella SlyA that are critical for transcriptional regulation
9. Trends in CD4+ Cell Counts, Viral Load, Treatment, Testing History, and Sociodemographic Characteristics of Newly Diagnosed HIV Patients in Osaka, Japan, From 2003 through 2017: A Descriptive Study
10. Model Quality Assessment Using a Statistical Program that Adopts a Side Chain Environment Viewpoint
11. Visualization of infectious disease occurrence trend and development of epidemiological analysis system
12. Correlates of laboratory-confirmed measles in Japan, 2011–2015
13. Respiratory Syncytial Virus Surveillance System in Japan: Assessment of Recent Trends, 2008–2015
14. Additional file 2: of Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor
15. Additional file 3: of Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor
16. Additional file 5: of Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor
17. Additional file 1: of Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor
18. Additional file 4: of Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor
19. Additional file 8: of Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor
20. Additional file 6: of Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor
21. Additional file 7: of Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor
22. Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry
23. Erratum: Tahara, M., et al. Measles Virus Hemagglutinin Protein Epitopes: The Basis of Antigenic Stability. Viruses 2016, 8, 216
24. Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor
25. Measles Virus Hemagglutinin Protein Epitopes: The Basis of Antigenic Stability
26. Amino acid substitutions in the heptad repeat A and C regions of the F protein responsible for neurovirulence of measles virus Osaka-1 strain from a patient with subacute sclerosing panencephalitis
27. Nationwide rubella epidemic--Japan, 2013
28. Enterohemorrhagic Escherichia coli outbreaks related to childcare facilities in Japan, 2010–2013
29. ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction
30. Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment:meeting new challenges
31. Ongoing increase in measles cases following importations, Japan, March 2014: times of challenge and opportunity
32. The Host Protease TMPRSS2 Plays a Major Role in In Vivo Replication of Emerging H7N9 and Seasonal Influenza Viruses
33. TMPRSS2 Is an Activating Protease for Respiratory Parainfluenza Viruses
34. Molecular evolution of attachment glycoprotein (G) gene in human respiratory syncytial virus detected in Japan 2008–2011
35. A Case of Atypical Hand-Foot-and-Mouth Disease Caused by Coxsackievirus A6: Differential Diagnosis from Varicella in a Pediatric Intensive Care Unit
36. Clinical Manifestations of Coxsackievirus A6 Infection Associated with a Major Outbreak of Hand, Foot, and Mouth Disease in Japan
37. United3D: A Protein Model Quality Assessment Program That Uses Two Consensus Based Methods
38. New Protein Structure Model Evaluation Methods That Include a Side-Chain Consensus Score for the Protein Modeling
39. Method for Predicting Homology Modeling Accuracy from Amino Acid Sequence Alignment: the Power Function
40. HUMAN FAMSD-BASE: High Quality Protein Structure Model Database for the Human Genome Using the FAMSD Homology Modeling Method
41. FAMSD: A Powerful Protein Modeling Platform that Combines Alignment Methods, Homology Modeling, 3D Structure Quality Estimation and Molecular Dynamics
42. A New Docking and Screening Method Using a New Operator Based upon Bioinformatics
43. Dynamic Influence of the Two Membrane-Proximal Immunoglobulin-Like Domains upon the Peptide-Binding Platform Domain in Class I and Class II Major Histocompatibility Complexes: Normal Mode Analysis
44. Dynamic Interaction among the Platform Domain and Two Membrane-Proximal Immunoglobulin-Like Domains of Class I Major Histocompatibility Complex: Normal Mode Analysis
45. Bioinformatics Based Ligand-Docking and in-Silico Screening
46. The SKE-DOCK server and human teams based on a combined method of shape complementarity and free energy estimation
47. Enterohemorrhagic Escherichia coli outbreaks related to childcare facilities in Japan, 2010-2013.
48. Protein structure prediction in CASP6 using CHIMERA and FAMS
49. Evaluation of Homology Modeling of the Severe Acute Respiratory Syndrome (SARS) Coronavirus Main Protease for Structure Based Drug Design
50. Fams-ace: A combined method to select the best model after remodeling all server models.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.